Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Radiotherapy and Oncology

• Publication date

  2009-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.radonc.2008.09.010PMID 18950881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.

  2006cited by this paper
• Predictive factors for acute esophageal toxicity in thoracic radiotherapy.

  2006influential reference
• Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.

  2005cited by this paper
• Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.

  2005cited by this paper
• Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.

  2005cited by this paper
• Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity.

  2005cited by this paper
• A review of radiation dose escalation trials for non-small cell lung cancer within the Radiation Therapy Oncology Group.

  2005cited by this paper
• Amifostine in chemoradiation therapy for non-small cell lung cancer: review of experience and design of a phase II trial assessing subcutaneous and intravenous bolus administration.

  2005cited by this paper
• Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.

  2005influential reference
• Dosimetric and clinical predictors for radiation-induced esophageal injury.

  2005cited by this paper
• "Anatomically-correct" dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics.

  2005cited by this paper
• Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma.

  2004cited by this paper
• Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.

  2004cited by this paper
• Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.

  2004cited by this paper
• Erratum: Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer ( International Journal of Radiation Oncology Biology Physics (2004) 58 (1258-1267))

  2004cited by this paper
• Open label multicenter trial of subcutaneous amifostine (Ethyol) in the prevention of radiation induced esophagitis and pneumonitis in patients with measurable, unresectable non-small cell lung cancer.

  2004cited by this paper
• Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.

  2003cited by this paper
• Radiotherapy patterns of care study in lung carcinoma.

  2003cited by this paper
• Management of unresectable non-small cell carcinoma of the lung (NSCLC).

  2003cited by this paper
• High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial.

  2002cited by this paper
• Comparison of three IMRT inverse planning techniques that allow for partial esophagus sparing in patients receiving thoracic radiation therapy for lung cancer.

  2002cited by this paper
• Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy.

  2001cited by this paper
• Pharmacological and Dietary Prophylaxis and Treatment of Acute Actinic Esophagitis During Mediastinal Radiotherapy

  2001cited by this paper
• 73.6 Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer.

  2001cited by this paper
• Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.

  2000cited by this paper
• Accelerated Hyperfractionation in Patients with Non-Small Cell Bronchogenic Cancers as a Cost-Effective and User- and Patient-Friendly Schedule

  2000cited by this paper
• Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer.

  1999influential reference
• Clinical and dosimetric predictors of radiation-induced esophageal toxicity.

  1999cited by this paper
• Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis.

  1999cited by this paper
• Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis.

  1997cited by this paper
• Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.

  1997cited by this paper
• The role of multimodality therapy in locoregional non-small cell lung cancer.

  1997cited by this paper
• 3-D Conformal Radiotherapy for Lung Cancer

  1996cited by this paper
• Erratum: Multimodality therapy in stage III non-small cell lung cancer (Ann Thorac Surg 1996;61:1564-72)

  1996cited by this paper
• Multimodality therapy in stage III non-small cell lung cancer.

  1996cited by this paper
• 3-D conformal radiotherapy for lung cancer. The Washington University experience.

  1996cited by this paper
• Radiotherapy in non-small cell lung cancer: optimal doses and schedules.

  1995cited by this paper
• The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo.

  1968cited by this paper

• Segmental bronchi radiation dose affected the progression of radiation pneumonitis in lung cancer patients

  2025cites this paper
• Development and validation of NTCP models for predicting acute esophagitis in carbon ion radiotherapy for thoracic malignancies

  2025cites this paper
• Dosiomics-guided deep learning for radiation esophagitis prediction in lung cancer: optimal region of interest definition via multi-branch fusion auxiliary learning.

  2025cites this paper
• Detecting radiation esophagitis using 18F-FAPI-04 PET/CT in patients with LA-ESCC treated with concurrent chemoradiotherapy

  2025cites this paper
• Decision tree-based machine learning algorithm for prediction of acute radiation esophagitis

  2025cites this paper
• Combined deep learning and radiomics in pretreatment radiation esophagitis prediction for patients with esophageal cancer underwent volumetric modulated arc therapy.

  2024cites this paper
• Chinese clinical practice guidelines for the prevention and treatment of radiation‐induced esophagitis

  2023cites this paper
• Locoregional breast radiotherapy including IMN: optimizing the dose distribution using an automated non-coplanar VMAT-technique

  2023cites this paper
• Dosimetric analysis of beam arrangement for intensity-modulated radiation therapy in the postoperative irradiation of thymoma

  2023cites this paper
• Predicting Radiation Esophagitis using 18F-FAPI-04 PET/CT in Patients with LA-ESCC Treated with Concurrent Chemoradiotherapy.

  2023cites this paper
• Effects of Radiotherapy on Survival of Esophageal Cancer Patients Receiving Immunotherapy: Propensity Score Analysis and Nomogram Construction

  2022cites this paper
• Prevention and management of acute esophageal toxicity during concomitant chemoradiotherapy for locally advanced lung cancer

  2021cites this paper
• Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancer

  2021cites this paper
• Predicting Severe Radiation Esophagitis in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: Construction and Validation of a Model Based in the Clinical and Dosimetric Parameters as Well as Inflammatory Indexes

  2021cites this paper
• Using fuzzy logics to determine optimal oversampling factor for voxelizing 3D surfaces in radiation therapy

  2020cites this paper
• Detecting spatial susceptibility to cardiac toxicity of radiation therapy for lung cancer

  2020cites this paper
• Multi-view radiomics and dosiomics analysis with machine learning for predicting acute-phase weight loss in lung cancer patients treated with radiotherapy

  2020cites this paper
• Efficacy of oral epigallocatechin-3-gallate solution administration during radiotherapy for non-small-cell lung cancer patients: A long-term observational study

  2020cites this paper
• Exploring the Relationship of Radiation Dose Exposed to the Length of Esophagus and Weight Loss in Patients with Lung Cancer.

  2020cites this paper
• The use of real-world evidence to audit normal tissue complication probability models for acute esophageal toxicity in non-small cell lung cancer patients.

  2020cites this paper
• Machine learning highlights the deficiency of conventional dosimetric constraints for prevention of high-grade radiation esophagitis in non-small cell lung cancer treated with chemoradiation

  2020cites this paper
• Dose-volume predictors of early esophageal toxicity in non-small cell lung cancer patients treated with accelerated-hyperfractionated radiotherapy.

  2019cites this paper
• Phase II Trial of Epigallocatechin-3-Gallate in Acute Radiation-Induced Esophagitis for Esophagus Cancer

  2019cites this paper
• Treatment of Locally Advanced Non-small Cell Lung Cancer with our Institutional Protocol of Split Course Concurrent Chemo Irradiation

  2018cites this paper
• Clinical, dosimetric, and position factors for radiation-induced acute esophagitis in intensity-modulated (chemo)radiotherapy for locally advanced non-small-cell lung cancer

  2018cites this paper
• Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer

  2018cites this paper
• Radiotherapy induced toxicity in lung cancer patients

  2018cites this paper
• clinical, dosimetric, and position factors for radiation-induced acute esophagitis in intensity-modulated (chemo)radiotherapy for locally advanced non-small-cell lung cancer

  2018cites this paper
• Clinical question:What are the principles of radiation therapy in the definitive management of stage III inoperable NSCLC?

  2018cites this paper
• Dosimetric Comparisons of Volumetric Modulated Arc Therapy with Three-Dimensional Conformal Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

  2017cites this paper
• Different definitions of esophagus influence esophageal toxicity prediction for esophageal cancer patients administered simultaneous integrated boost versus standard-dose radiation therapy

  2017cites this paper
• Guidelines for the treatment of lung cancer using radiotherapy.

  2017cites this paper
• Differences in Normal Tissue Response in the Esophagus Between Proton and Photon Radiation Therapy for Non-Small Cell Lung Cancer Using In Vivo Imaging Biomarkers.

  2017cites this paper
• Dosimetric advantages of intensity modulated radiation therapy in locally advanced lung cancer

  2017cites this paper
• Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer

  2017cites this paper
• A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials

  2017cites this paper
• Esophageal wall dose-surface maps do not improve the predictive performance of a multivariable NTCP model for acute esophageal toxicity in advanced stage NSCLC patients treated with intensity-modulated (chemo-)radiotherapy

  2017cites this paper
• How Efficacious is Ziverel® for Symptomatic Relief of Acute Radiation-Induced Esophagitis? Retrospective Study of Patients Receiving Oncologic Treatment

  2017cites this paper
• Overcoming toxicity-challenges in chemoradiation for non-small cell lung cancer.

  2016cites this paper
• Dosimetric evaluation of a simple planning method for improving intensity-modulated radiotherapy for stage III lung cancer

  2016cites this paper
• Dosimetric comparison of carbon ion and X-ray radiotherapy for Stage IIIA non–small cell lung cancer

  2016cites this paper
• Objectively Quantifying Radiation Esophagitis With Novel Computed Tomography-Based Metrics.

  2016cites this paper
• Acute esophagitis for patients with local-regional advanced non small cell lung cancer treated with concurrent chemoradiotherapy.

  2016cites this paper
• [Delineation of organs at risk and dose constraints].

  2016cites this paper
• Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.

  2016cites this paper
• Predictors for severe acute esophagitis in lung cancer patients treated with chemoradiotherapy: a systematic review

  2016cites this paper
• INVESTIGATION OF RADIATION INJURY IN THE ESOPHAGUS FROM DEFINITIVE CHEMORADIATION THERAPY USING NOVEL IMAGING BIOMARKERS

  2016cites this paper
• Oesophagus side effects related to the treatment of oesophageal cancer or radiotherapy of other thoracic malignancies.

  2016cites this paper
• Normal tissue considerations and dose-volume constraints in the moderately hypofractionated treatment of non-small cell lung cancer.

  2016cites this paper
• Multi-criteria optimization achieves superior normal tissue sparing in a planning study of intensity-modulated radiation therapy for RTOG 1308-eligible non-small cell lung cancer patients.

  2016cites this paper
• Radiation Effects in the Mediastinum and Surroundings: Imaging Findings and Complications.

  2016cites this paper
• Délinéation des organes à risque et contraintes dosimétriques

  2016cites this paper
• Nutrition support and dietary interventions for patients with lung cancer: current insights

  2016cites this paper
• Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study

  2015cites this paper
• Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.

  2015cites this paper
• Incidence and predictors of severe acute esophagitis and subsequent esophageal stricture in patients treated with accelerated hyperfractionated chemoradiation for limited-stage small cell lung cancer.

  2015cites this paper
• A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer.

  2015cites this paper
• Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy.

  2015cites this paper
• Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid)

  2015cites this paper
• The Role of IMRT in Lung Cancer : Guideline Recommendations

  2015cites this paper
• Oral glutamine supplementation reduces radiotherapy- induced esophagitis in lung cancer patients.

  2015cites this paper
• Dosimetric factors associated with weight loss during (chemo)radiotherapy treatment for lung cancer

  2014cites this paper
• Prediction of toxicity in concurrent chemoradiation for non-small cell lung cancer

  2014cites this paper
• Who wins the race of predicting chemoradiation-induced esophagitis? Is there anyone else to join the competition? In response to Tang et al.

  2014cites this paper
• Non-small cell lung cancer, version 1.2015.

  2014cites this paper
• [Intensity-modulated radiation therapy in non-small cell lung cancers].

  2014cites this paper
• NCCN Guidelines Version 1.2015 Panel Members Non-Small Cell Lung Cancer

  2014cites this paper
• A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer.

  2014cites this paper
• Acute phase response before treatment predicts radiation esophagitis in non-small cell lung cancer.

  2014cites this paper
• NCCN Non – Small Cell Lung Cancer , Version 1 . 2015 Clinical Practice Guidelines in Oncology

  2014cites this paper
• The prevalence of weight loss during (chemo)radiotherapy treatment for lung cancer and associated patient- and treatment-related factors.

  2014cites this paper
• Esophageal perforation during or after conformal radiotherapy for esophageal carcinoma

  2014cites this paper
• Predicting Esophagitis After Chemoradiation Therapy for Non-Small Cell Lung Cancer: An Individual Patient Data

  2013cites this paper
• Non-small Cell Lung Cancer

  2013cites this paper
• Small cell lung cancer.

  2013cites this paper
• Acute oesophageal toxicity related to paclitaxel-based concurrent chemoradiotherapy for non-small cell lung cancer.

  2013cites this paper
• Dosimetric and clinical predictors of acute esophagitis in lung cancer patients in Turkey treated with radiotherapy.

  2013cites this paper
• New approaches in the treatment of locally advanced non-small cell lung cancer

  2013cites this paper
• NCCN Small Cell Lung Cancer Clinical Practice Guidelines in Oncology

  2013cites this paper
• Prognostic parameters for acute esophagus toxicity in intensity modulated radiotherapy and concurrent chemotherapy for locally advanced non-small cell lung cancer.

  2013cites this paper
• Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis.

  2013cites this paper
• Predictive models of toxicity in intensity modulated radiotherapy

  2013influential citation
• Modèles prédictifs de toxicité en radiothérapie par modulation d’intensité

  2013influential citation
• Küçük Hücreli Dışı Akciğer Kanserinde Radyoterapi

  2013cites this paper
• Blockade of CD47 increases survival of mice exposed to lethal total body irradiation

  2013cites this paper
• Radiation-induced oesophagitis in lung cancer patients

  2012cites this paper
• Acute Esophagus Toxicity in Lung Cancer Patients After Intensity Modulated Radiation Therapy and Concurrent

  2012cites this paper
• Independent test of a model to predict severe acute esophagitis

  2012cites this paper
• [Esophageal toxicity of radiation therapy: clinical risk factors and management].

  2012cites this paper
• Esophageal tolerance to high-dose stereotactic ablative radiotherapy.

  2012cites this paper
• Small Cell Lung Cancer: Lung Neuroendocrine Tumors: NCCN Small Cell Lung Cancer Panel Members Initial Evaluation and Staging (SCL-1)

  2012cites this paper
• Clinical application of a novel hybrid intensity-modulated radiotherapy technique for stage III lung cancer and dosimetric comparison with four other techniques.

  2012cites this paper
• Clinical predictive factors for radiation pneumonitis and pulmonary fibrosis during split course concurrent chemoirradiation for locally advanced non-small cell lung cancer

  2012cites this paper
• Modeling the risk of radiation-induced acute esophagitis for combined Washington University and RTOG trial 93-11 lung cancer patients.

  2012cites this paper
• Intensity-modulated radiotherapy in the treatment of lung cancer.

  2012cites this paper
• [Helical tomotherapy in the treatment of malignant pleural mesothelioma: The impact of low doses on pulmonary and oesophageal toxicity].

  2012cites this paper
• Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy.

  2012cites this paper
• Clinical Investigation : Thoracic Cancer Acute Esophagus Toxicity in Lung Cancer Patients After Intensity Modulated Radiation Therapy and Concurrent Chemotherapy

  2012influential citation
• Intensity-modulated radiotherapy in the treatment of breast cancer.

  2012cites this paper
• Development of a multicomponent prediction model for acute esophagitis in lung cancer patients receiving chemoradiotherapy.

  2011cites this paper